Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Teva
Federal Trade Commission
Express Scripts
Cantor Fitzgerald
Daiichi Sankyo
QuintilesIMS
McKesson
Healthtrust

Generated: November 14, 2018

DrugPatentWatch Database Preview

Drugs in Development Information for Eculizumab

« Back to Dashboard

US Patents for Eculizumab

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Eculizumab ➤ Sign Up Quinazolinone derivatives as tubulin polymerization inhibitors Janssen Pharmaceutica NV (Beerse, BE) ➤ Sign Up
Eculizumab ➤ Sign Up Stabilizing alkylglycoside compositions and methods thereof Aegis Therapeutics LLC (San Diego, CA) ➤ Sign Up
Eculizumab ➤ Sign Up 2-oxo-1,2-dihydro-quinoline modulators of immune function Teva Pharmaceuticals Industries, Ltd. (Petach-Tikva, IL) ➤ Sign Up
Eculizumab ➤ Sign Up Posterior segment drug delivery ForSight Vision4, Inc. (Menlo Park, CA) ➤ Sign Up
Eculizumab ➤ Sign Up Directed engagement of activating Fc receptors Massachusetts Institute of Technology (Cambridge, MA) ➤ Sign Up
Eculizumab ➤ Sign Up Posterior segment drug delivery Forsight Vision4, Inc. (Menlo Park, CA) ➤ Sign Up
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for Eculizumab

Drugname Country Document Number Estimated Expiration Related US Patent
Eculizumab Austria 513818 2028-03-27 ➤ Sign Up
Eculizumab Australia 2009228945 2028-03-27 ➤ Sign Up
Eculizumab Canada 2716088 2028-03-27 ➤ Sign Up
Eculizumab European Patent Office 2260026 2028-03-27 ➤ Sign Up
Eculizumab Spain 2367760 2028-03-27 ➤ Sign Up
Eculizumab Japan 2011515451 2028-03-27 ➤ Sign Up
Drugname Country Document Number Estimated Expiration Related US Patent

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Teva
Fish and Richardson
Colorcon
AstraZeneca
Citi
Accenture
Healthtrust
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.